Drugs / tenofovir disproxil fumarate
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00804622 Comparator | Dec 2008 → Jun 2009 | chronic hepatitis B virus infection | The University of Hong Kong | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | tenofovir disproxil fumarate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00804622 ↗ |
| Route | Oral | “daily oral administration of telbivudine 600 mg and tenofovir disproxil fumarate 300 mg in combination given over 12 weeks” NCT00804622 ↗ |